Cyanocobalamin is not a suitable form of vitamin B12 for the treatment of optic neuropathies associated with raised plasma concentrations of cyanocobalamin
Cyanocobalamin (Vitamin B12)..............5000 mcg Benzyl Alcohol (preservative).................1.0% v/v Sodium Chloride.................................0.22% w/v Ammonium Sulfate...............................0.1% w/v Citric Acid..........................................0.01% w/v Sodium Citrate..................................0.008% w/v Inject subcutaneously or intramuscularly
Occasionally, the problem is not what they are consuming but that they just do not have the energy to continue
While less extensively researched than BPC-157, the formulation represents an interesting option for those exploring peptides for brain function
These documents detail clinical pharmacology, indications, contraindications, warnings, adverse reactions, and drug interactions based on the complete clinical development program
~197 marketed (market analysis)
